Latest filing published 23 Sept 2025 for BioCardia, Inc., €305k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -27.7%Entry US$1.48 · Close at T+365 US$1.07
- -44.8%Entry US$2.12 · Close at T+365 US$1.17
- -52.1%Entry US$2.42 · Close at T+365 US$1.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Andrew Scott Blank: trading record in brief
This profile gathers the share dealings of Andrew Scott Blank in BioCardia, Inc. In total, 15 filings cover trades dated from 30 April 2020 to 19 September 2025.
Purchases make up the whole of the open-market record (4 purchases, €921k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 11 share grants. 2025 to date brings 3 purchases and no sales.
In size, the median ticket on the buying side is €244k. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of -14.2%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 23 September 2025, reports an open-market purchase of €305k in BioCardia, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Andrew Scott Blank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 288,000 shares@ US$1.2523.0% of flowCommon StockSEC:0001437749-25-029652:0Canonical exit: 18 Dec 2025 (T+90)
- 72,289 shares@ US$2.0759.6% of flowCommon StockSEC:0001437749-25-022062:0Canonical exit: 28 Sept 2025 (T+90)
- 131,233 shares@ US$1.90516.6% of flowCommon StockSEC:0001437749-25-013198:0Canonical exit: 22 Jul 2025 (T+90)
- 111,000 shares@ US$3.0022.7% of flowCommon StockSEC:0001437749-24-028510:0
- 64,212 shares@ US$2.33610.3% of flowCommon StockSEC:0001437749-23-018550:0
- 148,809 shares@ US$1.6817.7% of flowCommon StockSEC:0001437749-22-029317:0
6 of 6 declarations
